Dr. Mammoser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Piedmont Brain Tumor Center
2001 Peachtree Rd NE
Atlanta, GA 30309Phone+1 404-605-2050Fax+1 404-355-8421- Is this information wrong?
Summary
- Dr. Aaron Mammoser is a neuro-oncologist in Marrero, LA and New Orleans, LA and is affiliated with multiple hospitals in the area, including West Jefferson Medical Center and University Medical Center. He received his medical degree from University at Buffalo, School of Medicine and Biomedical Sciences. He undertook his Neurology residency at the University of Michigan and subsequently completed a Neuro-Oncology fellowship from MD Anderson Cancer Center in Houston, TX. He was on faculty as a neuro-oncologist in the Department of Neurology at the University of Michigan prior to accepting his current position in the Neurosurgery Department
at LSU in New Orleans. He has been in practice 12 years.
Education & Training
- University of MichiganMS, Clinical Trial Design and Statistical Analysis, 2012 - 2013
- University of Michigan Rackham Graduate SchoolMS, 2011 - 2013
- University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2009 - 2011
- University of Michigan Health SystemResidency, Neurology, 2005 - 2009
- University of Michigan Health SystemInternship, Internal Medicine, 2005 - 2006
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2005
- SUNY Buffalo, Roswell Park Graduate DivisionMS, 1995 - 2000
- Cornell UniversityBS, 1990 - 1994
Certifications & Licensure
- AL State Medical License 2023 - 2024
- GA State Medical License 2023 - 2024
- LA State Medical License 2016 - 2024
- TN State Medical License 2023 - 2024
- MI State Medical License 2005 - 2017
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeuro-Oncology Certification
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Start of enrollment: 2008 Sep 01
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01
- Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Start of enrollment: 2016 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsCombined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.Yoshie Umemura, Daniel Orringer, Larry Junck, Maria L Varela, Molly E J West, Syed M Faisal, Andrea Comba, Jason Heth, Oren Sagher, Denise Leung, Aaron Mammoser, Shawn...> ;The Lancet. Oncology. 2023 Sep 1
- Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.Sepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, Mark D Anderson, Sajeel Chowdhary, Renato V LaRocca, Aaron G Mammoser, L Burt Nabors, Jeffrey J Olson, Reid C Thomps...> ;British Journal of Neurosurgery. 2023 Jun 7
- 11 citationsCancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.Tulika Ranjan, Soma Sengupta, Michael J Glantz, Richard M Green, Alexander Yu, Dawit Aregawi, Rekha Chaudhary, Ricky Chen, Mario Zuccarello, Christine Lu-Emerson, Hugh...> ;Cell Reports. Medicine. 2023 May 16
- Join now to see all
Journal Articles
- Hypercellularity Components of Glioblastoma Identified by High b-value Diffusion-Weighted ImagingPramanik PP, Parmar HA, Mammoser AG, Junck L, Kim MM, Tsien CI, Lawrence TS, Cao YC, Int J Radiat Oncol Biol Phys, 1/1/2015
- Gemcitabine Plus Radiation Therapy for High Grade Glioma: Long-term Results of a Phase I Dose-Escalation StudyKim M, Camelo-Piragua S, Schipper M, Tao Y, Normolle D, Junck L, Mammoser A, Betz B, Cao Y, Kim C, Heth J, Sagher O, Lawrence T, Tsien C, International Journal of Radiation Oncology*Biology*Physics, 1/1/2015
- Novel clinical trials in neuro-oncologyMammoser AG, Blas-Boria DE, Gilbert MR, Clin Investig, 1/1/2011
Books/Book Chapters
Abstracts/Posters
- Phase I Lead-in to a Phase II Factorial Study of Temozolomide plus Memantine, Mefloquine, and Metformin as Post-Radiation Adjuvant Therapy for Newly Diagnosed Glioblas...Marakas S, Groves MD, Mammoser A, Melguizo-Gavilanes I, Tremont-Lukats IW, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, De Groot JF,..., Journal of Clinical Oncology, 2018 ASCO Annual Meeting, Chicago, IL, 1/20/2018
- Primary CNS lymphoma; a review of the University of Michigan experience 2004-2013.Mammoser AG, Weathers S-PS, Seewald NJ, Taylor JMG, Junck L, Journal of Clinical Oncology, 2015 ASCO Annual Meeting, Chicago, IL, 1/1/2015
- A Phase I Dose-Escalation Study of Gemcitabine Plus Standard Radiation Therapy for Malignant High Grade Gliomas.Kim M, Schipper M, Cao Y, Junck L, Mammoser AG, Heth J, Sagher O, Lawrence T, Tsien C, Neuro-Oncology, Society for Neuro-Oncology 19th Annual Scientific Meeting, Miami, FL, 1/1/2014
- Join now to see all
Lectures
- "A Tour of Adult Primary Brain Tumors"1/1/2018
- "A Whirlwind Tour of Adult Primary Brain Tumors"1/1/2017
- "Immunotherapeutic Approaches in Glioma Treatment"1/1/2016
- Join now to see all
Press Mentions
- Brain Cancer Care in New Orleans Is Limited. This 5K Race Hopes to Change ThatSeptember 25th, 2018
- Piedmont Brain & Tumor CenterJuly 28th, 2023
Hospital Affiliations
- Piedmont Atlanta HospitalAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: